Sana Biotechnology, Inc. (SANA) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Non-GAAP Net Loss Per Common Share (Basic and Diluted) | 0.14 USD_per_share | FY2026-Q1 |
| Non-GAAP Net Loss | 38.8M | FY2026-Q1 |
| Research and Development Related Success Payments and Contingent Consideration | 8.4M | FY2026-Q1 |
Back to SANA overview · SANA earnings · SANA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.